Table 2.
Patient characteristics
| Author, year | Female (%) | Mean age (SD), years | Mean BMI (SD) | Mean HbA1c (SD) | Mean duration of T2DM (SD), years |
|---|---|---|---|---|---|
| Fonseca et al, 201325 | 37.7 | 56.1 (9.06) | 30.0 (5.20) | 8.8 (1.00) | 9.8 (5.95) |
| Gilman, 2013*26 | 51.5 | 53.8 (9.30) | 28.2 (5.30) | NR (NR) | NR (NR) |
| Abdulwahid, 2012*27 | 45.5 | 49.8 (12.58) | NR (NR) | 8.62 (0.20) | NR (NR) |
| Lukashevich, 2012*28 | NR | 55.1 (NR) | 28.0 (NR) | 8.78 (0.63) | 7.3 (NR) |
| Makdissi et al, 201229 | 45.5 | 53.5 (12.09) | 35.2 (4.74) | 7.74 (1.21) | NR (NR) |
| Moses et al, 2012*30 | 40.1 | 57.0 (10.54) | 29.2 (5.09) | 8.28 (0.85) | NR (NR) |
| Nogueira, 2012*31 | 57.1 | 56.7 (6.80) | 27.0 (2.60) | 8.1 (0.65) | 10.9 (6.68) |
| Violante et al, 201232 | 49.4 | 56.0 (7.92) | 31.2 (5.19) | 7.89 (0.62) | 8.0 (6.52) |
| Owens et al, 201133 | 52.8 | 58.1 (9.80) | 28.3 (4.70) | 8.15 (0.04) | NR (NR) |
| Hermansen et al, 200734 | 47.6 | 57.2 (8.85) | 31.0 (6.05) | 8.27 (0.71) | 9.9 (6.27) |
*Unpublished data.
HbA1c, glycosylated haemoglobin (%); BMI, body mass index (kg/m2); NR, not reported; T2DM, type 2 diabetes mellitus.